Catalyst Wire Dossier Catalyst Wire Dossier

TASCENSO ODT

FINGOLIMOD LAURYL SULFATE · Cycle Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TASCENSO ODT, covering 2021-12-23 to 2025-01-28. Get the full timeline:

Most recent: FDA Approved: TASCENSO ODT — Supplemental Application (Cycle Pharmaceuticals Ltd)

See pricing